The Impact of RDNs on Non-Communicable Diseases: Proceedings from The State of Food and Nutrition Series Forum.

Citation metadata

Publisher: Elsevier Science Publishers
Document Type: Report
Length: 466 words

Document controls

Main content

Abstract :

Abstract In the United States, nutrition-related morbidities are rising steadily at rates corresponding to increasing overweight and obesity in the population. Such morbidities take huge tolls on personal health and impose high costs on health care systems. In 2019, the Academy of Nutrition and Dietetics (Academy) and the Academy of Nutrition and Dietetics Foundation (Academy Foundation) embarked on a new project titled "The State of Food and Nutrition Series" to demonstrate the value of nutrition interventions led by registered dietitian nutritionists for individuals with the following 3 high-priority non-communicable diseases that affect many in the United States and globally: type 2 diabetes mellitus, chronic kidney disease, and hypertension. Poor nutritional status contributes to disease onset and progression in these non-communicable diseases, and appropriate medical nutrition therapy can prevent or delay worsening and ameliorate poor health outcomes. However, many people who have these conditions do not have access to an registered dietitian nutritionist, and consequently do not receive the nutrition care they need. On February 19-20, 2020 in Arlington, VA, as the first stage in The State of Food and Nutrition Series, the Academy and the Academy Foundation gathered health care policymakers, clinicians, and researchers from across the country for the State of Food and Nutrition Series Forum, where Academy leaders sought input to build a comprehensive research strategy that will quantify the impact of patient access to registered dietitian nutritionist--led nutrition interventions for type 2 diabetes mellitus, chronic kidney disease, and hypertension. This article summarizes the findings of that forum. Author Affiliation: (1) Altarum Fellow, Altarum, Ann Arbor, MI (2) Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, College of Osteopathic Medicine, Yakima, WA (3) clinical trials program, University of Tennessee Health Science Center, Memphis (4) New York University, New York (5) Academy of Nutrition and Dietetics, Chicago, IL * Address correspondence to: Alison Steiber, PhD, RDN, Academy of Nutrition and Dietetics, 120 S Riverside Plaza, Suite 2190, Chicago, IL, 60606. Article History: Received 18 September 2020; Accepted 18 February 2021 (footnote) STATEMENT OF POTENTIAL CONFLICT OF INTEREST C. P. Kovesdy received honoraria from Astra-Zeneca, Bayer, Cara Therapeutics, Reata, Tricida, and Takeda. A. Steiber is an employee of the Academy of Nutrition and Dietetics. No potential conflict of interest was reported by the other authors. (footnote) FUNDING/SUPPORT The Series was sponsored by Abbott Nutrition, Commission on Dietetic Registration, Diabetes Dietetic Practice Group, Elsine Roderick Memorial Fund, Foundation Research Endowment, Foundation Second Century Member Campaign, MedStar Georgetown University Hospital, National Kidney Foundation, Nutricia Advanced Medical Nutrition, Relypsa, a Vifor Pharma Group Company, Renal Dietitians Practice Group, and Weight Management Dietetic Practice Group. Byline: Jim Lee, MS (1), Kathaleen Briggs Early, PhD, RDN (2), Csaba P. Kovesdy, MD (3), Kristie Lancaster, PhD, RDN (4), Nicci Brown, MS, RDN (5), Alison Leah Steiber, PhD, RD [] (5,*)

Source Citation

Source Citation   

Gale Document Number: GALE|A686979903